Skip to content

A clinical trial to study the effects of two drugs, Ropivacaine and Levobupivacaine in patients undergoing surgery in Epidural anaesthesia.

Comparison of onset and duration of sensory and motor blockade between 0.75% Ropivacaine and 0.5% Levobupivacaine in lower abdominal surgeries under epidural anaesthesia - A one year hospital based randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/10/007341
Enrollment
90
Registered
2016-10-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Epidural Anaesthesia for lower abdominal surgery

Interventions

Intervention1: 0.5% LEVOBUPIVACAINE: 0.5% LEVOBUPIVACAINE contains only the pure S (â??)-enantiomer of bupivacaine. Control Intervention1: 0.75% ROPIVACAINE: 0.75% Ropivacaine is the pure S (-) enanti

Sponsors

Dr Aditi Suri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ASA Grade I and II

Exclusion criteria

Exclusion criteria: • Patient refusal. • Contraindications to epidural. Pre-existing neurological deficits in the lower extremities, and Cardiorespiratory diseases, neurological or psychological disease, hepatic, or renal disease. Bleeding diathesis

Design outcomes

Primary

MeasureTime frame
SENSORY 1.Onset 2.Duration 3.Highest level MOTOR 1.Onset 2.Duration Timepoint: SENSORY 1.Onset: time till T10 level attained. 2.Duration: time till two segment regression. 3.Highest level of sensory block achieved. MOTOR 1.Onset: Bromage scale III block. 2.Duration: Bromage scale score 0.

Secondary

MeasureTime frame
postoperative analgesia and haemodynamic changesTimepoint: duration of post operative analgesia 3.5-4hrs

Countries

India

Contacts

Public ContactAditi Suri

KLE UNIVERSITY, BELGAUM

drrajeshmane@gmail.com9455221628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026